Sustained complete remission in chemotherapy-refractory advanced lung adenocarcinoma with bevacizumab and iodine-125 seed implantation: A long-term case report
Abstract
RATIONALE: The introduction of small-molecule tyrosine kinase inhibitors and immune checkpoint inhibitors has transformed therapeutic strategies for lung adenocarcinoma, significantly improving the survival of eligible patients. However, the prognosis remains poor for those lacking actionable driver mutations and presenting with brain metastases, who typically exhibit a median survival of
Fields of Study & Subjects
Lung Cancer Diagnosis and Treatment
Lung Cancer Treatments and Mutations
Metastasis and carcinoma case studies
Publication details
- Journal / source
- Medicine
- Volume
- 105
- Issue
- 2
- Pages
- e47018–e47018
- Publication date
- 9 January 2026
- Language
- EN